CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

t315i mutation testing , page-9

  1. investoridol
    62 Posts.
    clock Created with Sketch.
    25/03/10
    11:17
    Post #: 6495644
    diersal, great questions. i would have thought all 100% patients have confirmed mutation status. maybe ask greg?
    also there is another question which is similar to your in queue for cxs. http://au.dearceo.net/investor-relations/487/chemgenex-pharmaceuticals-ltd/archive/124/are-there-any-results-of-omapro-on-patients-with-t3151-mutation-negative
    CXS Price at posting: 45.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.